Anthony Bonifazio brings more then 25 years of commercial experience in market access, advocacy, reimbursement, and sales across retina, cardiovascular and oncology.
Mr. Bonifazio joins Opthea from Astellas (former IVERIC BIO) where he served as Vice President, Access, Reimbursement and Market Development, spearheading the hiring and development of teams across access, reimbursement and thought leader advocacy to drive the successful commercialization and launch of Izervay® in geographic atrophy. During his tenure at Novartis, Mr. Bonifazio built a 180-person organization for the launch of the first physician-administered, buy and bill product in cardiology, shaping the commercial reimbursement program launch strategy across healthcare systems and cardiology accounts. He also developed the access and reimbursement strategy and team for the Beovu® launch in wet AMD. At Santen, he led the development of market access payer and reimbursement strategies, as well as patient services programs for the retina and glaucoma product portfolio. Mr. Bonifazio started his career in Genentech where he held roles of increasing responsibilities in sales and filed reimbursement across retina, oncology, and cardiovascular medicine.
Mr. Bonifazio holds a BS in Exercise Science from La Salle University, Philadelphia, and completed the executive leadership training at the UCLA Anderson School of Management, West Point Thayer Leadership Program.